Free

Details

  • Released
  • Updated
  • October 16, 2014
  • February 4, 2024

Features

NbN3 screenshot #1 for iPhone
NbN3 screenshot #2 for iPhone
NbN3 screenshot #3 for iPhone
NbN3 screenshot #4 for iPhone
NbN3 screenshot #5 for iPhone
🖼️Get Icon
Icons↘︎

About

This app provides a neuroscience-based nomenclature for psychotropic medications, reflecting current knowledge and aiding clinicians in making informed prescription decisions. It includes detailed information on pharmacology, mode of action, indications, efficacy, side effects, practical notes, and neurobiology.

Neuroscience-based nomenclature
Pharmacology and mode of action
Approved indications
Efficacy and side effects
Practical clinical notes
Neurobiology details
Links to IUPHAR
Show original description

What's New in NbN3

3.9.5

February 4, 2024

- Bug fixes.

User reviews

Status

Is this app still active?

Doesn’t open

The app is incredible but it’s not working. I can’t open it.

Doesn’t work anymore

This app doesn’t open anymore….

Wonderful app now dead

This used to be a wonderful app but now no longer works at all and does not appear to have been updated for a long time

Used to be very useful; non-functional now

The concept behind this app is very important. The classification of medicines used in Psychiatry requires a paradigm shift. This app was previously exceptionally useful to me. Unfortunately, now it is no longer functional with the latest version of iOS on my iPhone. It either doesn't open at all, or opens and immediately crashes. So it has become inoperable. An upgrade would be incredibly welcome!
Show more

Developer apps

FAQ

What is NbN3?

NbN3 is a medical application that provides a neuroscience-based nomenclature for psychotropic medications. It aims to reflect current pharmacological knowledge and assist clinicians in making rational treatment decisions.

What kind of information does NbN3 offer?

NbN3 includes details on pharmacology, mode of action, approved indications, efficacy and side effects, practical clinical notes, and neurobiology. It also provides links to the IUPHAR website for further pharmacology information.

Who developed NbN3?

NbN3 was developed by ECNP Research and Scholarship Stichting (De ECNP Research and Scholarship Foundation), a collaboration involving five international organizations: ECNP, ACNP, AsCNP, CINP, and IUPHAR.

How many medications are included in NbN3?

The second edition of NbN3 includes 130 medications, with 22 new medications added since the previous edition.

Is NbN3 available on multiple devices?

Based on the provided data, NbN3 is supported on iPhone and iPod devices.

How often is NbN3 updated?

NbN3 is an ongoing process, and updates, such as new editions, will be undertaken based on user feedback and new findings. The latest version was updated on February 4, 2024.

What is the age rating for NbN3?

NbN3 has an age rating of 12+, making it suitable for users aged 12 and above.

Does NbN3 have ads?

No, NbN3 does not contain advertisements. The application is free to use and does not feature any ads.